CRMD
CorMedix Inc
7.20$
-3.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -24.42 | -12.53 | -1.94 | -2.76 | -1.00 | -1.31 | -1.47 | -2.00 | -2.93 | -2.59 | -1.33 | -0.62 | -0.77 | -0.56 | -0.60 | -0.75 | -0.86 | 2.18 | |
| 6.18 | 0.06 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.18 | |
| – | 0.67 | 0.62 | 0.30 | 0.12 | 0.49 | 0.51 | 0.51 | 0.18 | 0.15 | 0.06 | 0.10 | 0.09 | 0.13 | 0.10 | 0.11 | 0.10 | 0.17 | |
| – | – | – | 0.30 | 0.12 | 1.16 | 2.65 | 0.53 | 0.19 | 0.14 | 0.06 | 0.10 | 0.09 | 0.13 | 0.10 | – | – | – | |
| 0.29 | -1.76 | 0.33 | -0.13 | 0.22 | -0.02 | 0.05 | 0.10 | 0.12 | 0.26 | 0.11 | -0.08 | -0.09 | 0.05 | 0.03 | 0.04 | -0.67 | 0.09 | |
| 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.04 | 0.01 | 0.01 | 0.00 | 0.03 | |
| – | – | -0.01 | 0.00 | 0.00 | -0.01 | -0.01 | -3.77 | 1.50 | 0.94 | 0.09 | -0.50 | 0.26 | -0.24 | -0.09 | -0.34 | 0.36 | -3.84 | |
| – | – | – | 0.00 | 0.00 | 0.14 | 0.00 | 0.00 | 0.00 | 0.00 | – | – | – | – | – | – | – | – | |
| – | – | – | 0.00 | 0.00 | 0.38 | 1.64 | 6.96 | 0.93 | 1.86 | 1.24 | 1.08 | 1.40 | 1.11 | – | 0.00 | – | – | |
| – | – | – | – | 0.56 | 0.19 | 0.00 | 1.20 | 0.99 | 0.68 | 0.41 | -0.01 | – | – | – | – | 0.00 | 1.87 | |
| 17.56 | 13.26 | 5.52 | 10.46 | 0.49 | 1.88 | 1.95 | 6.96 | 0.93 | 1.86 | 1.65 | 1.07 | 1.40 | 1.11 | 0.44 | 1.10 | 0.45 | 2.97 | |
| – | 0.73 | 3.58 | -2.76 | -0.50 | 0.56 | 0.46 | 1.19 | -0.49 | 0.21 | 0.41 | -0.05 | 0.90 | 0.30 | -0.25 | 0.01 | -0.05 | 1.31 | |
| -24.42 | -12.53 | -1.94 | -2.76 | -1.00 | -1.32 | -1.48 | -2.00 | -2.94 | -2.61 | -1.33 | -0.62 | -0.77 | -0.60 | -0.61 | -0.76 | -0.86 | 2.15 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.